Nuzenio

Advances Biotech

Advances Biotech news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 16 latest news signals 12 publisher sources 100/100 entity strength

Latest news

VERAXA Biotech Advances Antibody Therapeutics with Innovative BiTAC Platform - citybuzz -citybuzz - · Sat, 08 Aug 2026 00:18:46 GMTVERAXA Biotech Advances VXA-222 bsADC Program and Expands Patent Portfolio - citybuzz -citybuzz - · Fri, 07 Aug 2026 00:22:56 GMTVERAXA Biotech (VRXA) Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-Generation Antibody Technologies - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 18:30:00 GMTS.D.-born biotech advances potential Type 1 diabetes therapy through global trial - SiouxFalls.BusinessSiouxFalls.Business · Thu, 06 Aug 2026 14:35:40 GMTVERAXA Biotech Advances VXA-222 Cancer Program and Expands Patent Portfolio - citybuzz -citybuzz - · Thu, 06 Aug 2026 00:24:20 GMTScottish kidney disease biotech Mironid raises $46 million to advance rare disease pipeline - The Pharma LetterThe Pharma Letter · Wed, 05 Aug 2026 16:12:39 GMTKrystal Biotech Reports Strong 2Q 2026 VYJUVEK Revenue Growth and Advances Multi-Program Genetic Medicines Pipeline - Quiver QuantitativeQuiver Quantitative · Mon, 03 Aug 2026 11:15:00 GMTKelun-Biotech's TROP2 ADC sac-TMT Advances Toward First-Line TNBC Approval in China - BioPharma APACBioPharma APAC · Sun, 02 Aug 2026 18:34:30 GMT

Timeline

Sat, 08 Aug 2026 00:18:46 GMTVERAXA Biotech Advances Antibody Therapeutics with Innovative BiTAC Platform - citybuzz -
Fri, 07 Aug 2026 00:22:56 GMTVERAXA Biotech Advances VXA-222 bsADC Program and Expands Patent Portfolio - citybuzz -
Thu, 06 Aug 2026 18:30:00 GMTVERAXA Biotech (VRXA) Advances VXA-222 Cancer Program While Expanding Patent Portfolio for Next-Generation Antibody Technologies - Yahoo Finance
Thu, 06 Aug 2026 14:35:40 GMTS.D.-born biotech advances potential Type 1 diabetes therapy through global trial - SiouxFalls.Business
Thu, 06 Aug 2026 00:24:20 GMTVERAXA Biotech Advances VXA-222 Cancer Program and Expands Patent Portfolio - citybuzz -
Wed, 05 Aug 2026 16:12:39 GMTScottish kidney disease biotech Mironid raises $46 million to advance rare disease pipeline - The Pharma Letter

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Advances Biotech.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

12 distinct publisher/source names are currently connected to this entity page.